These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10455982)

  • 21. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
    Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
    Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor spleen cell isolation for augmentation of donor-cell chimerism in organ transplantation.
    Risaliti A; Corno V; Baccarani U; Ermacora A; Cautero N; Donini A; Anania G; Bresadola F
    Transplant Proc; 1998 Aug; 30(5):2454-5. PubMed ID: 9723535
    [No Abstract]   [Full Text] [Related]  

  • 24. An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies.
    Drezet A; Granata A; Lemarie C; Calmels B; Chabannon C
    Bone Marrow Transplant; 2016 Jul; 51(7):1007-9. PubMed ID: 26950377
    [No Abstract]   [Full Text] [Related]  

  • 25. CD34+ selected cells in clinical transplantation.
    Collins RH
    Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Processing of hematopoietic stem cell components for transplantation: variations in current practice.
    Rowley SD
    Transfusion; 1998 Jan; 38(1):1-4. PubMed ID: 9482385
    [No Abstract]   [Full Text] [Related]  

  • 27. [Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation].
    Klabusay M; Suková V; Korístek Z; Mayer J; Vorlícek J
    Cas Lek Cesk; 2003; 142(7):410-6. PubMed ID: 14515444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological aspects of haploidentical stem cell transplantation in children.
    Handgretinger R; Lang P; Schumm M; Pfeiffer M; Gottschling S; Demirdelen B; Bader P; Kuci S; Klingebiel T; Niethammer D
    Ann N Y Acad Sci; 2001 Jun; 938():340-57; discussion 357-8. PubMed ID: 11458522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
    Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
    J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123.
    Leemhuis T; Yoder MC; Grigsby S; Agüero B; Eder P; Srour EF
    Exp Hematol; 1996 Aug; 24(10):1215-24. PubMed ID: 8765497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemopoietic stem cell characterization.
    Lansdorp PM; Schmitt C; Sutherland HJ; Craig WH; Dragowska W; Thomas TE; Eaves CJ
    Prog Clin Biol Res; 1992; 377():475-84; discussion 485-6. PubMed ID: 1279716
    [No Abstract]   [Full Text] [Related]  

  • 32. Adult mouse hematopoietic stem cells: purification and single-cell assays.
    Ema H; Morita Y; Yamazaki S; Matsubara A; Seita J; Tadokoro Y; Kondo H; Takano H; Nakauchi H
    Nat Protoc; 2006; 1(6):2979-87. PubMed ID: 17406558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Absolute numbers of peripheral blood CD34+ hematopoietic stem cells prior to a leukapheresis procedure as a parameter predicting the efficiency of stem cell collection].
    Galtseva IV; Davydova YO; Gaponova TV; Kapranov NM; Kuzmina LA; Troitskaya VV; Gribanova EO; Kravchenko SK; Mangasarova YK; Zvonkov EE; Parovichnikova EN; Mendeleeva LP; Savchenko VG
    Ter Arkh; 2017; 89(7):18-24. PubMed ID: 28766536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of stem cell markers on mononuclear cells derived from heparinized cadaveric organ donors before and after disconnection from the respirator.
    Machaliński B; Paczkowska E; Hałasa M; Pabisiak K; Walczak M; Sieńko J; Kozik W; Ostrowski M; Syrenicz A; Sulikowski T; Machalińska A
    Transplant Proc; 2006; 38(1):16-9. PubMed ID: 16504653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor-derived mucosal epithelial cells after human hematopoietic cell transplantation are not derived from the CD34-positive fraction of the graft.
    Metaxas Y; Spyridonidis A; Bertz H; Finke J; Greiner J
    Leukemia; 2007 Oct; 21(10):2214-6. PubMed ID: 17541399
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successful hematologic reconstitution using CD34+ cells positively selected from cryopreserved autologous peripheral blood stem cells in a patient with malignant lymphoma].
    Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T
    Rinsho Ketsueki; 2000 Aug; 41(8):681-6. PubMed ID: 11020998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
    Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Flandrois G; Devys A; Stocco V; Cesbron A; Dehaut F; Moreau P; Harousseau JL; Mohty M
    Bone Marrow Transplant; 2009 Nov; 44(9):613-5. PubMed ID: 19308036
    [No Abstract]   [Full Text] [Related]  

  • 39. [Residual placental blood and bone marrow as sources of hematopoietic stem cells for allogenic stem cell transplantation. Comparative analysis of hematopoietic potential].
    Köhler A; Häfer R; Müller A; Zintl F
    Klin Padiatr; 1995; 207(4):215-8. PubMed ID: 7564155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.